BIORASIS Inc., is a start-up corporation to commercialize implantable biosensors using University of Connecticut (UCONN) spin-off technology. Biorasis Inc. is developing needle-implantable glucose and other analytes biosensors for use in drug development research as well as eventual use for human on-demand metabolic disease management. Our technology includes both miniaturized (0.5 mm x 0.5 mm x 5 mm) sensor platform (equipped with power source, signal processors and wireless communication with cell phones or PDAs), as well as biocompatible coatings that enables functioning of sensors for a period of 3 months ( and working to extend sensor operation up to one year). The continuous monitoring of body analytes is key in the diagnosis, prognosis and treatment of diseases, such as diabetes, atherosclerosis, liver and kidney abnormalities, etc.
Biorasis Inc.
Storrs
Ioannis Tomazos
www.bio-orasis.com
Comments